Innospec (IOSP)
Innospec R&D Expense: 4.60M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
IOSP R&D Expense Rankings
| Overall | 47th percentile | 933 of 1763 |
| Sector | 42nd percentile | 124 of 214 in Basic Materials |
| Industry | 55th percentile | 13 of 29 in Specialty Chemicals |
IOSP R&D Expense Range, Past 5 Years
| Minimum | 3.20M | Mar 2009 |
| Maximum | 5.00M | Dec 2009 |
| Average | 4.105M |
About R&D Expense
R&D expenses are a line item from many companies' income statements.
R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.
Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.
An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More
You may also be interested in these IOSP related companies
IOSP News
$IOSP Insider Sale: $1.1M of stock sold by Patrick Williams between May 14, 2012 - May 15, 2012 http://stks.co/3r1H
about 14 days ago by MarketBrief
about 14 days ago by MarketBrief
Innospec Schedules First Quarter 2012 Earnings Release and Conference Call
Apr 10, 8:45AM GlobeNewswire
Apr 10, 8:45AM GlobeNewswire
$IOSP filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3DEF
about 57 days ago by MarketBrief
about 57 days ago by MarketBrief
$IOSP filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3C5e
about 58 days ago by MarketBrief
about 58 days ago by MarketBrief
$IOSP filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3AnD
about 59 days ago by MarketBrief
about 59 days ago by MarketBrief
$IOSP filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/39FG
about 61 days ago by MarketBrief
about 61 days ago by MarketBrief
$IOSP filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3811
about 63 days ago by MarketBrief
about 63 days ago by MarketBrief
$IOSP filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/36nx
about 64 days ago by MarketBrief
about 64 days ago by MarketBrief
$IOSP filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/35ct
about 65 days ago by MarketBrief
about 65 days ago by MarketBrief
$IOSP filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/344T
about 66 days ago by MarketBrief
about 66 days ago by MarketBrief
$IOSP filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/32Df
about 68 days ago by MarketBrief
about 68 days ago by MarketBrief
Innospec Announces Retirement of Dr. Bob Bew and Appointment of Milton Blackmore as New Chairman
Feb 27, 8:30AM GlobeNewswire
Feb 27, 8:30AM GlobeNewswire
Innospec Schedules Fourth Quarter 2011 Earnings Release and Conference Call
Jan 19, 8:45AM GlobeNewswire
Jan 19, 8:45AM GlobeNewswire
$IOSP http://chart.ly/awfmiwp resting near all-time highs. wait for break w/ resistance.
about 309 days ago by traderengineer
about 309 days ago by traderengineer
You Can Follow Any or All of The @StockTwits50 Stocks Here: http://stk.ly/dn1T97 $FEIC $VMW $IOSP $TPCG $PII $LAVA $IPGP
about 330 days ago by StockTwits
about 330 days ago by StockTwits
$IOSP http://chart.ly/elv8sft Monthly. Building a nice base abv Supp. Held up ok despite the significant selling in May & June
about 332 days ago by 1nvestor
about 332 days ago by 1nvestor
$IOSP http://chart.ly/wbyqkmj Weekly chart. Recent downvolume is a little worrisome, but a break over 36 should see 38.
about 333 days ago by daytradingzoo
about 333 days ago by daytradingzoo
Jeffrey Gendell's Tontine Capital trims $IOSP stake http://bit.ly/lFjuo2
about 341 days ago by marketfolly
about 341 days ago by marketfolly
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| IOSP | 26.45 | -0.86 | -3.15% | 630.04M |
| IHS | 100.13 | -1.57 | -1.54% | 6.629B |
| IHI | 63.13 | -1.02 | -1.59% | |
| IHG | 22.28 | -0.51 | -2.24% | 6.634B |
| IHF | 61.44 | -0.82 | -1.32% | |
| IHC | 8.96 | +0.15 | +1.70% | 158.67M |
| IGV | 59.73 | -1.06 | -1.74% | |
| IGTE | 16.60 | -0.50 | -2.92% | 971.62M |
| IGT | 13.90 | -0.41 | -2.90% | 4.260B |
| IGR | 7.60 | -0.09 | -1.17% |
